Metformin Hydrochloride 500 mg + Glimepiride 4 mg Tablet (Glucim-M4)
Metformin HCl 500 mg + Glimepiride 4 mg
| Composition | Metformin HCl 500 mg + Glimepiride 4 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Blister) |
| MRP | ₹ 850 |
| Therapy | Cardiac + Diabetic — Sulphonylurea + biguanide combination (Sustained Release) |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Glucim-M4 (metformin hydrochloride 500 mg + glimepiride 4 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
See the full antidiabetic tablets range – manufacturer, supplier and PCD franchise: SGLT2 and DPP-4 inhibitors, glimepiride, gliclazide, metformin, voglibose and their combinations.
Schedule G: Metformin is listed in Schedule G of the Drugs Rules, 1945, so the pack carries the red-box caution “SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision”. Combinations that also contain a Schedule H molecule carry the Rx label too. See the Schedule G drugs list.
About Glucim-M4 SR Tablet
Glucim-M4 SR Tablet contains Metformin HCl 500 mg + Glimepiride 4 mg. The combination of high-dose Metformin and Glimepiride provides robust glycaemic control for type-2 diabetes inadequately managed on lower-strength preparations.
It is indicated for adults with type-2 DM who need glycaemic intensification while still on oral therapy.
Camrut Healthcare manufactures the Glucim-M range under WHO-GMP conditions for PCD pharma franchise across India.
Glucim-M4 का उपयोग (हिंदी में): टाइप 2 डायबिटीज़ (शुगर) की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Type-2 diabetes uncontrolled on dual oral therapy
- Patients needing intensified glycaemic control
- Glycaemic step-up before initiating insulin
Mechanism of Action
Metformin activates AMPK, suppressing hepatic glucose output and improving peripheral insulin sensitivity. Glimepiride closes ATP-sensitive K+ channels on pancreatic beta cells, triggering insulin secretion. The combination addresses both insulin resistance and inadequate insulin secretion.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast
- Titrate based on response
- Swallow whole — do not crush the SR tablet
- Monitor renal function and HbA1c periodically
Side Effects
- Hypoglycaemia
- GI upset (metformin)
- Weight gain (mild)
- Metallic taste
- Lactic acidosis (rare; avoid in renal impairment)
Contraindications & Precautions
- Type-1 diabetes
- Diabetic ketoacidosis
- eGFR < 30 mL/min/1.73m²
- Severe hepatic impairment
- Pregnancy and breastfeeding
Storage
Store below 25°C.
Part of our PCD pharma franchise range, available on a monopoly basis – see the cardiac diabetic PCD franchise product list (PDF). See our full tablets PCD pharma franchise. Comparing companies? See the top cardiac diabetic PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
Glucim-M4 SR Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products
- Glucim-M3 Forte SR Tablet — Metformin HCl 1000 mg + Glimepiride 3 mg
- Glucim-P1 SR Tablet — Glimepiride 1 mg + Metformin 500 mg + Pioglitazone 15 mg
- Emparon-M 5/500 Tablet — Empagliflozin 5 mg + Metformin 500 mg
